Miltenyi Biomedicine at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Miltenyi Biomedicine brings 1 presentation to ASH 2026 in New Orleans, and exhibits at Booth 3213. Its program centres on cell therapy for lymphoma. It hosts a session on manufacturing through clinical development and supports a symposium on CAR-T standards and sequencing.
| Organization | ASH 2026 Attendance |
|---|---|
Miltenyi Biomedicine Bergisch Gladbach, Germany | |
Biopharmaceutical arm of the Miltenyi group developing cell and gene therapies, including CAR T-cell therapies for lymphoma. | Booth Exhibiting at Booth 3213 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Symposium Fri Dec 11 7:00pm–10:00pm Accelerating CARs for Lymphoma: Expert Workshops on CAR-T Standards, Sequencing, and Emerging Cellular Therapy Platforms CAR-T as standard lymphoma care and what comes next, including dual-target, faster-manufactured, and in vivo versions that could widen patient access. Talk Mon Dec 14 8:00am–9:00am |
Find decision makers at Miltenyi Biomedicine
Tell us what you sell and we’ll find the people at Miltenyi Biomedicine most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction